Clinical and Genetic Features of 64 Young Male Paediatric Patients with Congenital Hypogonadotropic Hypogonadism (CHH)

Summary

Context

The diagnosis of congenital hypogonadotropic hypogonadism (CHH) in prepuberty has always been challenging. Here, we aimed at studying the clinical and genetic features of paediatric CHH, especially the phenotype of hypospadias and dual defects (patients showing hypothalamic and/or pituitary defects and testicular hypoplasia), so as to have a better understanding of CHH.

Design

The clinical and genetic features of CHH patients were analysed and the relationships between hypospadias, dual defects and genetics investigated.

Patients

Patients who visited Beijing Children's Hospital and were positively diagnosed with CHH.

Measurements

The collected data included sex hormones, MRI of the olfactory bulb, human chorionic gonadotropin (hCG) test and genetic testing. We analysed clinical features and genetic results, especially hypospadias and dual defects, and compared the stimulated testosterone (T) levels in patients with and without cryptorchidism.

Results

Sixty-four patients were positively diagnosed, and forty-seven (73.4%) had Kallmann Syndrome (KS). Four patients (6.3%) had hypospadias, including 2 KS. Micropenis combined with cryptorchidism was the most common phenotype (39%). Approximately 2/3 patients showed a poor response to hCG; 15 cases were diagnosed with dual defects, and there were no significant differences between those with and without cryptorchidism. Twenty-six cases in 51 patients (51%) were identified as having classical HH mutations, affecting 10 different genes, with oligogenic mutations in 5 cases (9.8%). The most common mutations were in PROKR2 (17.6%), FGFR1 (13.7%) and CHD7 (7.8%). The frequency of PROKR2 mutations was higher in dual HH when compared to other HH cases (6/15 vs 3/36, p=0.021).

Conclusions

Micropenis and/or cryptorchidism can serve as important signs for the diagnosis of HH in paediatrics and the coexistence of hypospadias, does not exclude the diagnosis of CHH, including KS or normosmic isolated HH (nIHH). <comment> Au: OK? Author: OK. Thank you!</comment>Testicular function may be impaired earlier than expected, and PROKR2 mutations need to be evaluated to identify presumed dual defects.

This article is protected by copyright. All rights reserved.

http://ift.tt/2x2ZBCy